SAN FRANCISCO, Oct. 9 /PRNewswire/ -- Burrill & Company and WR Hambrecht + Co (WRH+Co) are pleased to announce that they are establishing a Burrill/Hambrecht joint venture to be bankers of Initial Public Offerings. They will jointly pursue WR Hambrecht + Co's unique OpenIPO® auctions and the collaboration will target private healthcare companies where auctions will benefit investors and issuers alike.
Based on the rapidly changing dynamics in the equity capital markets, Burrill and WRH+Co are now able to jointly provide a valuable IPO alternative to leading private healthcare companies. OpenIPO® is an innovative auction process for distributing stock to individuals and institutions through a more efficient and equitable process. The auction process allows shares of an initial public offering to be allocated in an impartial way. All successful bidders pay the same price per share. OpenIPO® is designed to enable the issuer to:
The addition of OpenIPO is a key component to the previously announced expansion of Burrill & Company's Merchant Banking capabilities. Burrill Merchant Banking is building on the existing Strategic Partnering, M&A and Capital Raising Services to include traditional underwriting, independent equity research, sales and trading and Merchant Banking funds.
"We are delighted to form this collaboration with WR Hambrecht + Co," said G. Steven Burrill CEO, Burrill & Company, a San Francisco based global leader in life sciences with activities in Private Equity, Venture Capital, Merchant Banking and Media. "This is a major development as it brings together two industry leaders representing almost 100 years of combined experience in financing high growth companies and I believe it will open up a new chapter of biotechnology and life sciences fin
|SOURCE Burrill & Company; WR Hambrecht + Co|
Copyright©2009 PR Newswire.
All rights reserved